β1,2-xylosyltransferase Cxt1p is solely responsible for xylose incorporation into Cryptococcus neoformans glycosphingolipids

Eukaryotic Cell

Volumn 7, Issue 9, 2008, Pages 1611-1615

  Castle, Sherry A ^a   Owuor, Elizabeth A ^a   Thompson, Stephanie H ^a   Garnsey, Michelle R ^a   Klutts, J Stacey ^b,d   Doering, Tamara L ^b   Levery, Steven B ^a,c  

^a Univ of New Hampshire   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FILOBASIDIELLA NEOFORMANS;

BETA 1,2 XYLOSYLTRANSFERASE; BETA 1,2-XYLOSYLTRANSFERASE; FUNGAL PROTEIN; GLYCOSPHINGOLIPID; GLYCOSYLTRANSFERASE; XYLOSE;

ARTICLE; CHEMISTRY; CRYPTOCOCCUS NEOFORMANS; ENZYMOLOGY; GENETICS; METABOLISM;

CRYPTOCOCCUS NEOFORMANS; FUNGAL PROTEINS; GLYCOSPHINGOLIPIDS; PENTOSYLTRANSFERASES; XYLOSE;

EID: 51649096180     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00458-07     Document Type: Article

References (19)

1. Bar-Peled, M., C. L. Griffith, and T. L. Doering. 2001. Functional cloning and characterization of a UDP-glucuronic acid decarboxylase: the pathogenic fungus Cryptococcus neoformans elucidates UDP-xylose synthesis. Proc. Natl. Acad. Sci. USA 98:12003-12008.
2. Bennion, B., C. Park, M. Fuller, R. Lindsey, M. Momany, R. Jennemann, and S. B. Levery. 2003. Glycosphingolipids of the model fungus Aspergillus nidulans: characterization of GIPCs with oligo-α- mannose-type glycans. J. Lipid Res. 44:2073-2088.
3. Cheng, J., T.-S. Park, A. S. Fischl, and X. S. Ye. 2001. Cell cycle progression and cell polarity require sphingolipid biosynthesis in Aspergillus nidulans. Mol. Cell. Biol. 21:6198-6209.
4. Dickson, R. C., and R. L. Lester. 1999. Yeast sphingolipids. Biochim. Biophys. Acta 1426:347-357.
5. Dickson, R. C., and R. L. Lester. 2002. Sphingolipid functions in Saccharomyces cerevisiae. Biochim. Biophys. Acta 1583:13-25.
6. Georgopapadakou, N. H. 2000. Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthase. Expert Opin. Investig. Drugs 9:1787-1796.
7. Griffith, C. L., J. S. Klutts, L. Zhang, S. B. Levery, and T. L. Doering. 2004. UDP-glucose dehydrogenase plays multiple roles in the biology of the pathogenic fungus Cryptococcus neoformans. J. Biol. Chem. 279:51669-51676.
8. Gutierrez, A. L., L. Farage, M. N. Melo, R. S. Mohana-Borges, Y. Guerardel, B. Coddeville, J. M. Wieruszeski, L. Mendonca-Previato, and J. O. Previato. 2007. Characterization of glycoinositolphosphoryl ceramide structure mutant strains of Cryptococcus neoformans. Glycobiology 17:1-11C.
9. Heise, N., A. L. S. Gutierrez, K. A. Mattos, C. Jones, R. Wait, J. O. Previato, and L. Mendonca-Previato. 2002. Molecular analysis of a novel family of complex glycoinositolphosphoryl ceramides from Cryptococcus neoformans: structural differences between encapsulated and acapsular yeast forms. Glycobiology 12:409-420.
10. Klutts, J. S., and T. L. Doering. 2008. Cryptococcal xylosyltransferase 1 (Cxt1p) from Cryptocococus neoformans plays a direct role in the synthesis of capsule polysaccharides. J. Biol. Chem. 283:14327-14334.
11. Klutts, J. S., S. B. Levery, and T. L. Doering. 2007. A β-1,2-xylosyltransferase from Cryptococcus neoformans defines a new family of glycosyltransferases. J. Biol. Chem. 282:17890-17899.
12. Lester, R. L., and R. C. Dickson. 1993. Sphingolipids with inositolphosphate-containing head groups. Adv. Lipid Res. 26:253-274.
13. Levery, S. B. 2005. Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol. 405:300-369.
14. Levery, S. B., M. S. Toledo, A. H. Straus, and H. K. Takahashi. 1998. Structure elucidation of sphingolipids from the mycopathogen Paracoccidioides braziliensis: an immunodominant α-galactofuranose residue is carried by a novel glycosylinositol phosphorylceramide antigen. Biochemistry 37:8764-8775.
15. Levery, S. B., M. S. Toledo, A. H. Straus, and H. K. Takahashi. 2001. Comparative analysis of glycosylinositol phosphorylceramides from fungi by electrospray tandem mass spectrometry with low-energy collision-induced dissociation of Li adduct ions. Rapid Commun. Mass Spectrom. 15:2240-2258.
16. Moyrand, F., B. Klaproth, U. Himmelreich, F. Dromer, and G. Janbon. 2002. Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans. Mol. Microbiol. 45:837-849.
17. Nagiec, M. M., E. E. Nagiec, J. A. Baltisberger, G. B. Wells, R. L. Lester, and R. C. Dickson. 1997. Sphingolipid synthesis as a target for antifungal drugs. Complementation of the inositol phosphorylceramide synthase defect in a mutant strain of Saccharomyces cerevisiae by the AUR1 gene. J. Biol. Chem. 272:9809-9817.
18. Toledo, M. S., S. B. Levery, B. Bennion, L. L. Guimaraes, S. A. Castle, R. Lindsey, M. Momany, C. Park, A. H. Straus, and H. K. Takahashi. 2007. Analysis of glycosylinositol phosphorylceramides expressed by the opportunistic mycopathogen Aspergillus fumigatus. J. Lipid Res. 48:1801-1824.
19. Zhong, W., M. W. Jeffries, and N. H. Georgopapadakou. 2000. Inhibition of inositol phosphorylceramide synthase by aureobasidin A in Candida and Aspergillus species. Antimicrob. Agents Chemother. 44:651-653.